We're just 6 months away from @keystoneSymposia.bsky.social Beyond #Antibiotics : Emerging Strategies Combating #BacterialInfection, May 2026 in Breckenridge! 👉Scholarship and short talk abstract deadlines are Jan 7! 🧐 keysym.us/KSBeyondAntibiotics26 #KSBeyondAntibiotics26

Come join us in Breckenridge next May!

Come join us at @mcgill.ca as an assistant professor in virus-host interactions! Please share widely. mcgill.wd3.myworkdayjobs.com/en-US/McGill...

Big shoutout to @olayarendueles.bsky.social @julielebris.bsky.social , @nathaliechen.bsky.social, @dariavantyne.bsky.social and Adeline Supandy—such an awesome team effort from the #VanTyneLab at Pitt! 💫 Great to see phage work move forward together! #PittsburghPhageProgram

🔬 The spotlight continues! We’re excited to introduce the next incredible member of the #PittsburghPhageProgram team — meet Dr. @dariavantyne.bsky.social, whose work is helping push the boundaries of what’s possible in #phagetherapy. #InfectiousDiseases #P3 #VanTyneLab

Behind every patient story, every discovery, and every #phage, there’s a dedicated team making it happen. Over the next few weeks, we’re excited to introduce the people who power the #PittsburghPhageProgram — starting with Dr. Ghady Haidar.🧫✨

Emerging strains of a deadly ‘superbug’ seem to have picked up an advantage over other micro-organisms: a chemical weapon that kills competing bacteria https://go.nature.com/4lb8279

Shoutout to @dariavantyne.bsky.social, our Head of Phage Biology and Discovery, for her leadership in #phagetherapy. P3's latest clinical impact was given the spotlight in Contagion Live! Read more on how phage therapy is transforming treatment options: 🔗 tinyurl.com/Contagion-Live

Excited to share our latest, out today in @naturemicrobiol.bsky.social Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant Enterococcus faecium www.nature.com/articles/s41... @idpittstop.bsky.social

👋 We're the Pittsburgh Phage Program (P3)! Based at Pitt, we advance precision medicine using phages—viruses that kill bacteria. We fight antibiotic resistance through compassionate use & clinical trials. Follow for 🔬research, 💡phage facts, 📢success stories! #PhageTherapy #P3

How does avi-caz treatment lead to broad-spectrum treatment failure? Our awesome Peds ID faculty and labbie @rapskiid.bsky.social shows how, by longitudinal sequencing, genotyping, and phenotyping. Congrats Glenn! @dariavantyne.bsky.social @aleciarokes.bsky.social journals.asm.org/doi/10.1128/...

I remember seeing Dr. O’Brien at seminars around Boston and Cambridge and being wowed at his stature, both physically and in the AMR field. And that was before I knew whose father he was… www.nejm.org/doi/abs/10.1...

From our lab to yours, happy holidays!

🧪 Please share! Spring 2025 Microbiology & Immunology Diversity Scholars Program Applications open Dec 4-Jan 15. The program seeks to provide biomedical research opportunities for Pittsburgh area undergrads who are from underrepresented or disadvantaged backgrounds www.pmi.pitt.edu/research/mid...

JOB CLAXON! I am recruiting a post-doctoral researcher on a BBSRC-funded project (36 months) on the genetics and functional genomics of vancomycin resistance in enterococci. Further details here: edzz.fa.em3.oraclecloud.com/hcmUI/Candid... Please DM or email me if you want to discuss this post.

Silver lining of an otherwise awful week: attending #RBM2024 with these fabulous folks. A great meeting full of awesome science!

Check out this collection in the ASM journal Spectrum which highlights some recent advances on #Phagetherapy #MicroSky-with @dariavantyne.bsky.social journals.asm.org/phage-therap...